Beta-Lactamases of Gram negative bacteria: Never-ending clockwork!;β-Lactamases de bacilles à Gram négatif: Le mouvement perpétuel!

Annales de Biologie Clinique

Volumn 64, Issue 1, 2006, Pages 37-51

  Philippon, A ^a   Arlet, G ^b  

^a AP HP ^*  (France)

^b HÔPITAL TENON   (France)

Author keywords

Cefotaxime; Ceftazidime; Gram negative bacteria; Imipenem; Novel lactamase; Resistance

Indexed keywords

BETA LACTAMASE; MONOBACTAM DERIVATIVE;

ANIMAL; ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENZYMOLOGY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; METABOLISM; REVIEW; SALMONELLOSIS; ZOONOSIS;

ANIMALS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MONOBACTAMS; SALMONELLA INFECTIONS; ZOONOSES;

ACINETOBACTER BAUMANNII; AEROMONAS PUNCTATA; ANIMALIA; CITROBACTER FREUNDII; ENTEROBACTER; ENTEROBACTERIACEAE; HAFNIA ALVEI; MORGANELLA MORGANII; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; SALMONELLA;

EID: 32044468901     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Philippon A, Labia R, Jacoby G. Extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1989 ; 33 (Suppl. 5) : 1131-6.
2. Sirot D. Extended-spectrum plasmid-mediated beta-lactamases. J Antimicrob Chemother 1995 ; 36 (Suppl. A) : 19-34.
3. Arlet G, Philippon A. Les nouvelles β-lactamases à l'aube du troisième millénaire. Rev Franç Lab 2003 ; 352 : 41-55.
4. Bradford PA. Extended-spectrum beta-lactamases in the 21st century : characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001 ; 14 : 933-51.
5. Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae : considerations for diagnosis, prevention and drug treatment. Drugs 2003 ; 63 : 353-65.
6. Bonnet R. Growing group of extended-spectrum beta-lactamases : the CTX-M enzymes. Antimicrob Agents Chemother 2004 ; 48 : 1-14.
7. Humeniuk C, Arlet G, Gautier V, Grimont P, Labia R, Philippon A. β-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother 2002 ; 46 : 3045-9.
8. Giakkoupi P, Tzouvelekis LS, Tsakris A, Loukova V, Sofianou D, Tzelepi E. IBC-1, a novel integron-associated class A β-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob Agents Chemother 2000 ; 44 : 2247-53.
9. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003 ; 41 : 3542-7.
10. Aubert D, Naas T, Nordmann PIS. 1999 increases expression of the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa. J Bacteriol 2003 ; 185 : 5314-9.
11. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa : novel developments and clinical impact. Antimicrob Agents Chemother 2003 ; 47 : 2385-92.
12. de Champs C, Chanal C, Sirot D, et al. Frequency and diversity of class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France : a 2 year prospective study. J Antimicrob Chemother 2004 ; 54 : 634-9.
13. Bellais S, Poirel L, Fortineau N, Decousser JW, Nordmann P. Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis. Antimicrob Agents Chemother 2001 ; 45 : 2965-8.
14. Decousser JW, Poirel L, Nordmann P. Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens. Antimicrob Agents Chemother 2001 ; 45 : 3595-8.
15. Petrella S, Clermont D, Casin I, Jarlier V, Sougakoff W. Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii : genetic diversity of beta-lactamases within the Citrobacter genus. Antimicrob Agents Chemother 2001 ; 45 : 2287-98.
16. Rossolini GM, Franceschini N, Lauretti L, et al. Cloning of a Chryseobacterium (Flavobacteriuni) meningosepticum chromosomal gene (blaA (CME) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases. Antimicrob Agents Chemother 1999 ; 43 : 2193-9.
17. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases : the quiet before the storm ? Clin Microbiol Rev 2005 ; 18 : 306-25.
18. Tribuddharat C, Moore RA, Baker P, Woods DE. Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition. Antimicrob Agents Chemother 2003 ; 47 : 2082-7.
19. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino-and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990 ; 34 : 2200-9.
20. Philippen A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002 ; 46 : 1-11.
21. Hanson ND. AmpC beta-lactamases : what do we need to know for the future ? J Antimicrob Chemother 2003 ; 52 : 2-4.
22. Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob Agents Chemother 2004 ; 48 : 533-7.
23. Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC. Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei : first report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J Clin Microbiol 2005 ; 43 : 2608-12.
24. Nakano R, Okamoto R, Nakano Y, et al. CFE-1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene originating from Citrobacter freundii. Antimicrob Agents Chemother 2004 ; 48 : 1151-8.
25. Yan JJ, Hong CY, Ko WC, et al. Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob Agents Chemother 2004 ; 48 : 1353-6.
26. Barnaud G, Labia R, Raskine L, Sanson-Le Pors MJ, Philippen A, Arlet G. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol Lett 2001 ; 195 : 185-90.
27. Barnaud G, Benzerara Y, Gravisse J, et al. Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate. Antimicrob Agents Chemother 2004 ; 48 : 1040-2.
28. Hidri N, Barnaud G, Decré D, et al. Resistance to ceftazidime associated with a S-220-Y substitution in the omega loop of the AmpC β-lactamase of a Serratia marcescens clinical isolate. J Antimicrob Chemother 2005 ; 55 : 496-9.
29. Mammeri H, Poirel L, Bemer P, Drugeon H, Nordmann P. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC β-lactamase of a Serratia marcescens clinical isolate. Antimicrob Agents Chemother 2004 ; 48 : 716-20.
30. Raimondi A, Sisto F, Nikaido H. Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome. Antimicrob Agents Chemother 2001 ; 45 : 2331-9.
31. Poirel L, Nordmann P. Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support. Curr Pharm Biotechnol 2002 ; 3 : 117-27.
32. Urban C, Rahal J. Mechanisms and detection of carbapenem resistance in Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. Rev Med Microbiol 2004 ; 15 : 63-72.
33. Naas T, Nordmann P. OXA-type beta-lactamases. Curr Pharm Des 1999 ; 5 : 865-79.
34. Armand-Lefevre L, Leflon-Guibout V, Bredin J, et al. Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production. Antimicrob Agents Chemother 2003 ; 47 : 1165-8.
35. Pottumarthy S, Moland ES, Juretschko S, Swanzy SR, Thomson KS, Fritsche TR. NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerg Infect Dis 2003 ; 9 : 999-1002.
36. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001 ; 45 : 1151-61.
37. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City : a new threat to our antibiotic armamentarium. Arch Intern Med 2005 ; 165 : 1430-5.
38. Wachino J, Doi Y, Yamane K, et al. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop. Antimicrob Agents Chemother 2004 ; 48 : 2905-10.
39. Vourli S, Giakkoupi P, Miriagou V, Tzelepi E, Vatopoulos AC, Tzouvelekis LS. Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol Lett 2004 ; 234 : 209-13.
40. Batchelor M, Hopkins K, Threlfall EJ, et al. bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005 ; 49 : 1319-22.
41. Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM. Beta-lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J Antimicrob Chemother 2005 ; sous presse.
42. Izumiya H, Mori K, Higashide M, et al. Identification of CTX-M-14 beta-lactamase in a Salmonella enterica serovar Enteritidis isolate from Japan. Antimicrob Agents Chemother 2005 ; 49 : 2568-70.
43. Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005 ; 55 : 846-52.
44. Weill FX, Lailler R, Praud K, et al. Emergence of extended-spectrum-beta- lactamase (CTX-M-9)-producing multiresistant strains of Salmonella enterica serotype Virchow in poultry and humans in France. J Clin Microbiol 2004 ; 42 : 5767-73.
45. Weill FX, Perrier-Gros-Claude JD, Demartin M, Coignard S, Grimont PA. Characterization of extended-spectrum-beta-lactamase (CTX-M-15)-producing strains of Salmonella enterica isolated in France and Senegal. FEMS Microbiol Lett 2004 ; 238 : 353-8.
46. Allen KJ, Poppe C. Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada. Can J Vet Res 2002 ; 66 : 137-44.
47. Carattoli A, Tosini F, Giles WP, et al. Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob Agents Chemother 2002 ; 46 : 1269-72.
48. Chen S, Zhao S, White DG, et al. Characterization of multiple- antimicrobial-resistant salmonella serovars isolated from retail meats. Appl Environ Microbiol 2004 ; 70 : 1-7.
49. Gupta A, Fontana J, Crowe C, et al., The national antimicrobial resistance monitoring system pulseNet working group. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 2003 ; 188 : 1707-16.
50. Kruger T, Szabo D, Keddy KH, et al. Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa. Antimicrob Agents Chemother 2004 ; 48 : 4263-70.
51. Lee JH, Jung HI, Jung JH, et al. Dissemination of transferable AmpC-type beta-lactamase (CMY-10) in a Korean hospital. Microb Drug Resist 2004 ; 10 : 224-30.
52. Liebana E, Batchelor M, Clifton-Hadley FA, Davies RH, Hopkins KL, Threlfall EJ. First report of Salmonella isolates with the DHA-1 AmpC beta-lactamase in the United Kingdom. Antimicrob Agents Chemother 2004 ; 48 : 4492.
53. Liebana E, Gibbs M, Clouting C, et al. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom. Microb Drug Resist 2004 ; 10 : 1-9.
54. Navarro F, Perez-Trallero E, Marimon JM, Aliaga R, Gomariz M, Mirelis B. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother 2001 ; 48 : 383-9.
55. Pitout JD, Reisbig MD, Mulvey M, et al. Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC beta-lactamase, CMY-2. J Clin Microbiol 2003 ; 41 : 4578-82.
56. Poppe C, Martin LC, Gyles CL, et al. Acquisition of resistance to extended-spectrum cephalosporins by Salmonella enterica subsp. enterica serovar Newport and Escherichia coli in the turkey poult intestinal tract. Appl Environ Microbiol 2005 ; 71 : 1184-92.
57. Yan JJ, Ko WC, Chiu CH, Tsai SH, Wu HM, Wu JJ. Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan. Emerg Infect Dis 2003 ; 9 : 323-8.
58. Zhao S, White DG, McDermott PF, et al. Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob Agents Chemother 2001 ; 45 : 3647-50.
59. Aarestrup FM, Hasman H, Olsen I, Sorensen G. International spread of bla(CMY-2)-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar Heidelberg isolate stemming from the importation of a boar by Denmark from Canada. Antimicrob Agents Chemother 2004 ; 48 : 1916-7.
60. Espie E, de Valk H, Vaillant V, Quelquejeu N, Le Querrec F, Weill FX. An outbreak of multidrug-resistant Salmonella enterica sero-type Newport infections linked to the consumption of imported horse meat in France. Epidemiol Infect 2005 ; 133 : 373-6.
61. Hanson ND, Moland ES, Hossain A, Neville SA, Gosbell IB, Thomson KS. Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases. J Antimicrob Chemother 2002 ; 49 : 1011-4.